-+ 0.00%
-+ 0.00%
-+ 0.00%
MicroTech Medical wins South Korea marketing approval for LinX continuous glucose monitor
Share
Listen to the news
MicroTech Medical wins South Korea marketing approval for LinX continuous glucose monitor
  • MicroTech Medical received South Korea marketing clearance for its LinX continuous glucose monitoring system for adults.
  • The approval expands the company’s access in East Asia, supporting international scale-up and overseas revenue growth.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MicroTech Medical Hangzhou Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260714-12243927), on July 14, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending